Invicta Diagnostic Limited operates in the diagnostic services space, offering radiology and pathology solutions through a hub-and-spoke structure across the Mumbai Metropolitan Region. The company functions under the brand name “PC Diagnostics,” providing a mix of routine and specialised tests supported by a central laboratory and multiple centres. Its core operations revolve around imaging, pathology, and teleradiology services, positioned to serve both walk-in users and referred cases from healthcare partners. Through its network of hubs and spokes, the company has created a presence in key urban clusters, focusing on accessibility and integrated diagnostic offerings that cater to diverse medical requirements.
Applying for the Invicta Diagnostic IPO involves following a standard online application process through a demat and trading account. Investors can log in to their account, navigate to the IPO section, and select the Invicta Diagnostic IPO from the list of available issues. After reviewing the details provided in the prospectus, applicants can enter the number of lots they wish to apply for and submit the application using UPI authentication. Once the payment mandate is approved through a UPI app, the application is recorded with the exchange. Applicants can later check their application status through the official exchange website or their broker platform based on the timelines disclosed in the company’s offer documents.
For more details, visit the Invicta Diagnostic Limited IPO page.
Invicta Diagnostic Limited IPO Details and Objectives
Details
| Information
|
IPO Date
| December 1, 2025 to December 3, 2025
|
Issue Size
| 33,08,800 shares (aggregating up to ₹28.12 Cr)
|
Price Band
| ₹80 to ₹85 per share
|
Lot Size
| 1600 shares
|
Listing At
| NSE, SME
|
Purpose of the IPO
Timeline of Invicta Diagnostic Limited IPO
Event
| Date
|
|---|
IPO Open Date
| Mon, Dec 1, 2025
|
IPO Close Date
| Wed, Dec 3, 2025
|
Tentative Allotment
| Thu, Dec 4, 2025
|
Initiation of Refunds
| Fri, Dec 5, 2025
|
Credit of Shares to Demat
| Fri, Dec 5, 2025
|
Tentative Listing Date
| Mon, Dec 8, 2025
|
Cut-off time for UPI mandate confirmation
| 5 PM on Wed, Dec 3, 2025
|
Pricing & Lot Size of Invicta Diagnostic Limited IPO
Price Band for the IPO
Minimum Lot Size and Application Details
Application
| Lots
| Shares
| Amount
|
Individual investors (Retail) (Min)
| 2
| 3,200
| ₹2,72,000
|
Individual investors (Retail) (Max)
| 2
| 3,200
| ₹2,72,000
|
S-HNI (Min)
| 3
| 4,800
| ₹4,08,000
|
S-HNI (Max)
| 7
| 11,200
| ₹9,52,000
|
B-HNI (Min)
| 8
| 12,800
| ₹10,88,000
|
Invicta Diagnostic Limited IPO Application Process
The Invicta Diagnostic Limited IPO application process can be completed online through your trading platform. Below is a step-by-step guide to applying for the IPO:
Step 1: Login to Your Trading Platform
Access your trading account using the broker's app or website.
Step 2: Navigate to the IPO Section
Go to the IPO section to view active IPO listings.
Step 3: Select the Open IPO and Click Apply
Locate Invicta Diagnostic Limited IPO in the list of available IPOs and click the ‘Apply’ button.
Step 4: Enter the Quantity of Shares You Wish to Apply For
Specify the number of shares (minimum lot size: 1600 shares) within the price band of ₹80 to ₹85 per share.
Step 5: Provide Your UPI ID
Enter your UPI ID for payment authorization and ensure sufficient funds in your bank account.
Step 6: Confirm the Application
Review your application details and confirm the UPI mandate before 5 PM on the last application day.
Step 7: Complete the Process and Wait for Allotment
Submit the application and monitor the allotment status to check if shares have been allocated to you.
Financial Health and Performance
Key Financial Metrics
Total Assets: Grew from ₹43.99 crore in FY24 to ₹34.90 crore as of Sept 2025.
Total income: Reached ₹17.08 crore in FY25.
Profit After Tax (PAT): Stood at ₹4.08 crore for Sept 2025.
Net Worth: Recorded at ₹23.68 crore in FY25.
Reserves and Surplus: Recorded at ₹14.42 crore (Sept 2025), growing steadily over the years.
EBITDA: Stood at ₹6.77 crore in Sept 2025.
Recent Performance and Growth Prospects
The company has shown steady expansion in its asset base, reflecting ongoing operational development.
Its income profile indicates a consistent flow of revenue from diagnostic services across its network.
Profitability remains stable, supported by disciplined cost management and service demand.
The organisation’s net worth demonstrates gradual strengthening over time.
Reserves and surplus have increased progressively, highlighting prudent financial retention and internal growth.
Operating performance reflects healthy margins, indicating efficient utilisation of resources and diagnostic capacity.
Investment Risks and Opportunities
Potential Risks of Investing in the IPO
The company operates in a competitive healthcare segment, where changes in demand patterns or operational challenges can affect performance.
Expansion plans depend on successful execution, availability of resources, and timely setup of new diagnostic centres, which may influence future outcomes.
Opportunities and Growth Potential
The company’s hub-and-spoke structure provides scope for expanding service accessibility across urban regions.
Plans to establish additional diagnostic centres create room for wider reach and further enhancement of its integrated pathology and radiology offerings.
Key Performance Indicator (KPI)
KPI
| Values
|
ROE
| 44.28%
|
ROCE
| 42.00%
|
Debt/Equity
| 0.26
|
RoNW
| 36.25%
|
PAT Margin
| 16.38%
|
EBITDA Margin
| 30.57%
|
Price to Book Value
| 5.26
|
Market Capitalization
| ₹106.86 Cr.
|
Invicta Diagnostic Limited IPO Registrar & Lead Managers
Registrar
| Lead Manager(s)
|
|---|
Bigshare Services Pvt.Ltd.
| Socradamus Capital Pvt.Ltd.
|
Company Address of Invicta Diagnostic Limited Ltd.
Invicta Diagnostic Ltd. 1 GF, Plot 217, Ambavat Bhavan N.M Joshi Marg Delisle Road Mumbai, Maharashtra, 400013
Phone: 022 - 4971 0036
Email: investors@pcdiagnostics.in
Website: https://www.pcdiagnostics.in/
Conclusion
Invicta Diagnostic Limited’s public offering outlines key information about its operations, financial position, and planned utilisation of funds. The company functions through a structured network of diagnostic centres and a central laboratory, offering radiology and pathology services across the Mumbai Metropolitan Region. The IPO details, timelines, and application steps provide clarity for individuals reviewing the offer document and related disclosures.
Applicants who choose to participate can follow the standard online application process through their trading platform, with UPI authentication required for payment confirmation. The offer document remains the primary source for understanding the company’s objectives, financial information, and operational framework. Reviewing these disclosures helps in forming an informed view of the IPO based on available public information.
Interested in more opportunities? Check out our Upcoming IPO section for new listings and don’t forget to check your Invicta Diagnostic IPO allotment status.